Sign in to view content

Phase 1/2 Clinical Trial of Intravitreal 4D-125 AAV Gene Therapy in Patients with Advanced XLRP: Interim Safety & Preliminary Activity

Cagri G Besirli, MD, PhD, FASRS

Video
Published 2021

Related

Suprachoroidally delivered gene therapy via non-viral DNA nanoparticles
Christine Kay, MD
On Demand Cases, Courses, and Papers
2019
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Gene Therapy in Pediatric Retina Patients at the Bascom Palmer Eye Institute: What I Have Learned
Audina M. Berrocal, MD FASRS
Annual Meeting Talks
2019

Category: Hereditary Retinal Disease & Genetics

See more